Emergent BioSolutions signs contract modification award for CNJ-016

4 hours ago 1

Emergent BioSolutions (NYSE:EBS) announced a modification to its contract to provide its smallpox vaccine, CNJ-016, to the Administration for Strategic Preparedness and Response, part of the U.S. Department of Health and Human Services.
The administration has opted to secure additional

Recommended For You